Cargando…
CRISPR/Cas9-targeting of CD40 in hematopoietic stem cells limits immune activation mediated by anti-CD40
Inflammatory bowel diseases (IBD) are complex, multifactorial disorders characterized by chronic relapsing intestinal inflammation. IBD is diagnosed around 1 in 1000 individuals in Western countries with globally increasing incident rates. Association studies have identified hundreds of genes that a...
Autores principales: | Wang, Rui, Graham, Sean, Sun, Ning, McCarthy, Donna, Peng, Ruoqi, Erickson, Jamie, Oconnor, Liz, Zhu, Xiaochun, Wurbel, Marc, Dunstan, Robert, Westmoreland, Susan, Chung, Namjin, Ghayur, Tariq, Gu, Jijie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064223/ https://www.ncbi.nlm.nih.gov/pubmed/32155151 http://dx.doi.org/10.1371/journal.pone.0228221 |
Ejemplares similares
-
CRISPR/Cas9 Screens Reveal Multiple Layers of B cell CD40 Regulation
por: Jiang, Chang, et al.
Publicado: (2019) -
CD40–CD40L in Neurological Disease
por: Ots, Heather D., et al.
Publicado: (2022) -
Adipocytes in their (CD)40s
por: Bertola, Adeline, et al.
Publicado: (2023) -
CD40-CD40L Interaction in Immunity Against Protozoan Infections
por: Chamekh, Mustapha
Publicado: (2007) -
The Role of CD40/CD40 Ligand Interactions in Bone Marrow Granulopoiesis
por: Mavroudi, Irene, et al.
Publicado: (2011)